TCM
AMED

TD Capital Management’s Amedisys AMED Stock Holding History

TD Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-199
Closed -$19.6K – 694
2025
Q2 		$19.6K Hold
199
– – ﹤0.01% 323
2025
Q1 		$18.4K Hold
199
– – ﹤0.01% 259
2024
Q4 		$18.1K Hold
199
– – ﹤0.01% 250
2024
Q3 		$19.2K Hold
199
– – ﹤0.01% 251
2024
Q2 		$18.3K Buy
+199
New +$18.5K ﹤0.01% 245

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TD Capital Management's AMED Position: Q3 2025 in Review

TD Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 199 shares — an estimated $19.6K sold.

TD Capital Management first reported a position in AMED in Q2 2024 and held it in 5 quarters. The position peaked at $19.6K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • TD Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • TD Capital Management sold 199 Amedisys shares in Q3 2025, an estimated $19.6K.
  • TD Capital Management first reported a position in Amedisys in Q2 2024 and held it in 5 quarters.
  • TD Capital Management's Amedisys position peaked at $19.6K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on TD Capital Management's 13F filing for Q3 2025, filed 24 Nov 2025.